Vaccines against SARS-CoV-2 have been found to be highly effective and safe in both clinical trials and real-world settings.
1-7 Breakthrough infection, which is defined as COVID-19 infection after an individual has completed all required doses of a SARS-CoV-2 vaccine with a typical 14-day lag period, is rare in the general population.
5,6,8 In the US, 22 115 breakthrough infection cases were reported to the Centers for Disease Control and Prevention (CDC) after approximately 183 million persons received full vaccination by September 27, 2021.
9,10 However, because most of the breakthrough cases were asymptomatic or had mild disease,
9 surveillance data likely reflect underreported cases.